Janney Capital Upgrades Bio-Techne (TECH) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Bio-Techne Releases First Quarter Fiscal 2016 Results
October 28, 2015 7:01 AM EDTMINNEAPOLIS, Oct. 28, 2015 /PRNewswire/ --Â Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2015.
First Quarter 2016 Snapshot
Increased first quarter revenue by 4% to $112.4 million. Delivered first quarter adjusted earnings of $29.4 million, down 10% from the prior year due to FX headwinds and the timing of acquisitions in the prior year. Generated operating cash flow of $31.8 million. Continued the trend of double-digit growth in China. Achieved solid growth in the BioPharma end-markets, with a return to... More